Modern Obesity Management: The Role of GLP-1–Based Therapies

Author: Dr. Md. Abdul Bari Robel, MBBS, DEM
Diabetes, Thyroid, Obesity & Hormone Specialist

Introduction

Obesity is a chronic disease associated with diabetes, hypertension, fatty liver disease, sleep apnea, infertility, heart disease and several cancers. Modern treatment combines lifestyle intervention with evidence-based medicines. GLP-1 receptor agonists have transformed obesity treatment by producing clinically meaningful weight loss while improving metabolic health.

Asian BMI Classification

BMI (kg/m²)	Category
18.5–22.9	Normal
23.0–24.9	Overweight (Asian)
25.0–29.9	Obesity I (Asian)
≥30	Obesity II

Benefits of Weight Loss

Weight Loss	Expected Benefit
5%	Improved glucose and blood pressure
10%	Better fatty liver, lipids and mobility
≥15%	Major metabolic improvement in selected patients

GLP-1 Receptor Agonists

GLP-1 receptor agonists mimic the natural incretin hormone GLP-1. They reduce appetite, increase satiety, slow gastric emptying, and improve glucose-dependent insulin secretion, leading to weight loss and better glycaemic control.

GLP-1–Based Medicines

Medicine	Class	Main Benefit	Common Side Effects	Additional Benefit
Liraglutide	GLP-1 RA	Weight loss	Nausea, vomiting	Improves glycaemia
Semaglutide	GLP-1 RA	Greater weight loss	GI symptoms	Cardiometabolic benefit in appropriate patients
Tirzepatide	Dual GIP/GLP-1 RA	Substantial weight loss	GI symptoms	Improves glucose and weight

Who May Benefit?

• Adults with obesity or overweight with weight-related complications.
• People with type 2 diabetes needing weight reduction.
• Patients who have not achieved sufficient weight loss with lifestyle therapy alone.

Lifestyle Still Matters

Medicines work best when combined with calorie reduction, healthy food choices, regular physical activity, adequate sleep and behavioural support.

Figure (Placeholder)

Healthy lifestyle → GLP-1 therapy (selected patients) → Weight loss → Improved glucose, blood pressure, lipids and quality of life.

Frequently Asked Questions

Question	Answer
Are GLP-1 medicines insulin?	No. They are different medicines that mimic the GLP-1 hormone.
Will I lose weight without dieting?	Lifestyle changes improve results and help maintain weight loss.
Can everyone use these medicines?	No. Suitability should be assessed by a qualified physician.
What are the most common side effects?	Nausea, vomiting, diarrhoea and constipation are common, especially during dose escalation.

Key Messages

• Obesity is a chronic disease, not a lack of willpower.
• Lifestyle therapy is the foundation of treatment.
• GLP-1–based medicines can provide clinically meaningful weight loss in appropriate patients.
• Treatment should always be individualized and supervised by a healthcare professional.

References

• ADA Standards of Care in Diabetes (latest edition).
• AACE Clinical Practice Guidelines for Obesity.
• EASO Obesity Management Guidelines.
• SELECT, STEP and SURMOUNT clinical trial publications.